WMFC is an affiliate of the IWMF. Below we are offering some of the publications/booklets offered through the IWMF.
About WM Fact Sheet 2018 – English
By Guy Sherwood, M.D., 2014 A comprehensive review of immunology as it relates to WM. Revised Linda Nelson, 2018
Glossary and Abbreviations
Guy Sherwood, M.D., Bret Blakeslee, Sue Herms, & Peter DeNardis, 2015
Guy Sherwood, M.D. 2007. Revised by Sue Herms and Linda Nelson 2016
Questions and Answers
Revised 2010/2014 Guy Sherwood and Sue Herms, Revised 2017 Sue Herms and Linda Nelson
Alkylating Agents and Nucleoside Analogs Suzanne Herms, 2016 Updated 2019
This Guide discusses alkylating agents, such as chlorambucil (Leukeran), cyclophosphamide (Cytoxan), melphalan (Alkeran) and bendamustine (Bendeka, Treanda, Levact), as well as nucleoside analogs, such as fludarabine (Fludara) and cladribine (2CdA or Leustatin).
Corticosteroids and Immunomodulators Suzanne Herms, 2016 Updated 2019
This Guide includes corticosteroids, such as prednisone, prednisolone, and dexamethasone, as well as immunomodulators (IMiDs), such as thalidomide (Thalomid), lenalidomide (Revlimid), and pomalidamide (Actimid or Pomalyst).
Monoclonal Antibodies Suzanne Herms, 2016 Updated 2019
This Guide discusses monoclonal antibodies, such as rituximab (Rituxan or Mabthera), ofatumumab (Arzerra), and alemtuzumab (Campath)
Proteasome Inhibitors Suzanne Herms, 2016 Updated 2019
This Guide includes proteasome inhibitors, such as bortezomib (Velcade), carfilzomib (Kyprolis), and ixazomib (Ninlaro).
Targeted Therapies/Pathway Inhibitors Suzanne Herms, 2016 Updated 2019
This Guide discusses targeted therapies/pathway inhibitors to B-cell signaling, such as ibrutinib (Imbruvica) and everolimus (RAD001 or Afinitor).
Guide to WM and LPL (UK) Shirley D’Sa, M.D. 2014, updated 2017
This booklet is provided by the IWMF Affiliate Waldenstrom’s UK (WMUK). The drugs mentioned in the booklet are noted by their generic names and by their UK-specific trade names and may/may not be available in UK/US (or elsewhere) unless in the context of a clinical trial.
Clinical Practice Guide for the Treatment of WM (Australia) Dipti Talaulikar, M.D., Constantine Tam M.D. et al 2016
This booklet is a consensus established by the Australian Medical Scientific Advisory Group, which consists of a panel of haematologists across Australia, and it is provided by the IWMF Affiliate (WMozzies) in Australia.
Guide to WM (Germany) Christian Buske, M.D. and George Hess, M.D. 2014
This booklet is provided by the IWMF-Affiliate Morbus Waldenstrom (MOWA) in Germany.